| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 286,673 | 281,130 | 389,257 | 300,906 | | Cost of Revenue | 205,085 | 196,316 | 287,425 | 213,015 | | | Gross Profit | 81,588 | 84,814 | 101,832 | 87,891 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 91,041 | 105,557 | 121,721 | 115,339 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,851 | 5,961 | 7,045 | 7,321 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,304) | (26,704) | (26,934) | (34,769) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,693 | 58,768 | 990 | 1,906 | | Earnings Before Interest And Taxes | (12,611) | 32,064 | (25,944) | (32,863) | | Interest Expense | 3,008 | 2,937 | 3,487 | 3,804 | | Income Before Tax | (15,619) | 29,127 | (29,431) | (36,667) | | Income Tax Expense | 161 | (187) | (13) | 188 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,780) | 29,314 | (29,418) | (36,855) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,780) | 29,314 | (29,418) | (36,855) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,780) | $29,314 | ($29,418) | ($36,855) |
|
0.51% Nasdaq 
0.02 (0.36%) 
Income Statement
